(S)-Enzaplatovir (Synonyms: (S)-BTA-C585) |
| Catalog No.GC62750 |
Le (S)-Enzaplatovir ((S)-BTA-C585) est l'énantiomère S de l'Enzaplatovir. Le (S)-Enzaplatovir présente des activités antivirales avec une CE50 de 56 nM pour le virus respiratoire syncytial (VRS) (brevet WO2011094823A1 composé 77).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1323077-88-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77)[1].
[1]. Jeffrey Peter Mitchell, et al. Compounds for treating respiratory syncytial virus infections. WO2011094823A1
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *